F.D.A. Reviewing Deaths in Anemia Drug Study
September 27th, 2008 by
Federal health officials said that they were reviewing a higher rate of deaths among patients treated with a Johnson & Johnson anemia drug in a German study of stroke patients.
Posted in Anemia, Johnson & Johnson Inc, Stroke, Food and Drug Administration, Drugs (Pharmaceuticals), Medicine and Health